These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8471967)

  • 21. Changes in lymphoid organs, peripheral blood and in homing of lymphocytes after administration of local anaesthetics.
    Dráberová L; Nouza K
    Folia Biol (Praha); 1983; 29(3):238-49. PubMed ID: 6873398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological manifestations for the protective effect of miliacin in organs of immunogenesis after treatment with methotrexate.
    Zheleznova AD; Zheleznov LM; Shtil AA; Frolov BA
    Bull Exp Biol Med; 2007 Oct; 144(4):575-9. PubMed ID: 18642717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the interaction of lymphotropic cytostatic agent treatment and graft-versus-host (GVH) reaction in mice.
    Anderlik P; Szeri I; Bános Z
    Ann Immunol Hung; 1975; 18():53-6. PubMed ID: 17349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correction of immune and hematopoietic system disorders in experimental toxic hepatitis with Lacto Flor].
    Askarov TA
    Lik Sprava; 2004; (5-6):71-3. PubMed ID: 15605828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
    Vacca A; Di Stefano R; Caloro D; Ranieri G; Dammacco F
    Drugs Exp Clin Res; 1993; 19 Suppl():23-6. PubMed ID: 8625779
    [No Abstract]   [Full Text] [Related]  

  • 26. An overview on anticancer activities of the Viscum album extract Isorel.
    Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
    Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FLT3-ligand administration inhibits liver metastases: role of NK cells.
    Péron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
    J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental study on the combined treatment of UFT with etoposide against mouse Lewis lung carcinoma].
    Takechi T; Nakano K; Uchida J; Takeda S
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):235-40. PubMed ID: 8434961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
    Padjas A; Lesisz D; Lankoff A; Banasik A; Lisowska H; Bakalarz R; Góźdź S; Wojcik A
    Toxicol Appl Pharmacol; 2005 Dec; 209(2):183-91. PubMed ID: 15885733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of nitrosomethylurea derivatives in the combined chemotherapy of experimental tumors].
    Krutova TV; Ostrovskaia LA
    Eksp Onkol; 1986; 8(5):47-50. PubMed ID: 3780511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):79-87. PubMed ID: 9464333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of taurine on leucocyte function.
    Wang L; Zhao N; Zhang F; Yue W; Liang M
    Eur J Pharmacol; 2009 Aug; 616(1-3):275-80. PubMed ID: 19490912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A morphofunctional evaluation of the immunomodulating action of nitrosomethylurea].
    Potapov IuN; Khaleev DV; Krutova TV
    Eksp Klin Farmakol; 1995; 58(3):48-50. PubMed ID: 7663298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modulating effect of immunotherapy with modified tumor cells in transplantable lymphoma].
    Bratus' GG; Darchuk GF; Komissarenko VG; Nastenko EP
    Eksp Onkol; 1987; 9(2):36-40. PubMed ID: 3582237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics in antitumor effects of organic silicon related compounds].
    Fukushima K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2173-81. PubMed ID: 2544147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma.
    Iigo M; Nishikata K; Hoshi A
    J Biol Response Mod; 1990 Aug; 9(4):426-30. PubMed ID: 2395006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunomodulating mechanism of the antitumor effect of asterin].
    Smirnov VV; Mishenkova EL; Grinevich IuA; Petrenko GT; Martynenko SV
    Antibiot Khimioter; 1990 Jun; 35(6):31-4. PubMed ID: 2400290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
    Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
    Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.